Physician

Vassilios A. Dimitropoulos, M.D.

According to 2025 Medicare claims, Vassilios Dimitropoulos, M.D. (NPI: 1194838045) practices dermatology in the Niles, MI market, with the plurality of this provider's patient population coming from Berrien, MI. This provider's primary affiliated billing organization is ST JOSEPH DERMATOLOGY AND VEIN CLINIC PLLC (NPI: 1407309560; TIN: 270422873) and primary practice location at 49085-8607.

Dimitropoulos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,345 traditional Medicare patients, billed 14,350 HCPCS/CPT codes, and received $1,069,258 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 704 prescription claims across 291 beneficiaries totaling $238,673 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 20 records totaling $112,614. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $672,254 to $1,069,258. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $170,540 to $238,673. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$545K$1.1M2015 Medicare payment: $672,254 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $630,257 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $820,437 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $932,435 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,037,388 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $914,889 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $953,091 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $954,265 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,089,135 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,069,258 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,4056,888$672,254
20161,2416,256$630,257
20171,3827,639$820,437
20181,6299,519$932,435
20191,99610,695$1,037,388
20201,67410,147$914,889
20211,76510,476$953,091
20222,02011,100$954,265
20232,29614,468$1,089,135
20242,34514,350$1,069,258

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$186K$372K2015 Drug cost: $170,540 (USD; Tot_Drug_Cst)2016 Drug cost: $149,268 (USD; Tot_Drug_Cst)2017 Drug cost: $79,308 (USD; Tot_Drug_Cst)2018 Drug cost: $112,842 (USD; Tot_Drug_Cst)2019 Drug cost: $173,397 (USD; Tot_Drug_Cst)2020 Drug cost: $371,635 (USD; Tot_Drug_Cst)2021 Drug cost: $320,267 (USD; Tot_Drug_Cst)2022 Drug cost: $245,606 (USD; Tot_Drug_Cst)2023 Drug cost: $185,040 (USD; Tot_Drug_Cst)2024 Drug cost: $238,673 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015362954$170,540
2016356905$149,268
20174441,029$79,308
20185291,187$112,842
2019415961$173,397
20204551,136$371,635
2021359822$320,267
2022293599$245,606
2023274630$185,040
2024291704$238,673

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth503569$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,6332,634$62
17000Destruction of precancer skin growth, 1 growth774986$42
88305Pathology examination of tissue using a microscope, intermediate complexity9132,650$28
17003Destruction of precancer skin growth, 2-14 growths5573,154$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate1504,419$11,668
Triamcinolone AcetonideTriamcinolone Acetonide1123,461$1,666
KetoconazoleKetoconazole782,150$1,069
MetronidazoleMetronidazole15414$936
TretinoinTretinoin11300$839

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$74ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.17$112,539ABBVIE INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vassilios A. Dimitropoulos, M.D.?

Tedicare shows public-source Medicare data for Vassilios A. Dimitropoulos, M.D. (NPI 1194838045), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vassilios A. Dimitropoulos, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vassilios A. Dimitropoulos, M.D.?

Vassilios A. Dimitropoulos, M.D. is linked to ST JOSEPH DERMATOLOGY AND VEIN CLINIC PLLC (billing NPI 1407309560) in the available physician profile data.

Does Vassilios A. Dimitropoulos, M.D. have Open Payments data?

Vassilios A. Dimitropoulos, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.